UK
Udai Kumar Verma
About Udai Kumar Verma
Data last updated:
Udai Kumar Verma is a Director at Zerich Pharma Private Limited (since 2015). The companies operate in Healthcare and Pharma. Zerich Pharma Private Limited reported revenue of ₹17.6 Lakh (FY 2024). Earlier, Udai Kumar Verma was a Director at Senechio Pharma Private Limited (2011–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zerich Pharma Private Limited U24230DL2015PTC284692 | Director | 31 Aug 2015 | 2015 | ₹17.6 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Senechio Pharma Private Limited U51397DL2011PTC220092 | Director | 31 May 2011 | 2011 | ₹4.85 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Udai Kumar Verma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Kumar Verma | 07766718 | Zerich Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Udai Kumar Verma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Udai Kumar Verma
Udai Kumar Verma currently holds 1 directorship: Zerich Pharma Private Limited (Director, since 31 Aug 2015, revenue ₹17.6 Lakh (FY 2024)).
Udai Kumar Verma was first appointed on 31 May 2011 as Director at Senechio Pharma Private Limited. The most recent appointment on record is 31 Aug 2015 at Zerich Pharma Private Limited.
Udai Kumar Verma held 1 earlier board appointment: Senechio Pharma Private Limited (Director, 31 May 2011 to 26 Apr 2018).
The current boards of Udai Kumar Verma's companies include Rajesh Kumar Verma (Zerich Pharma Private Limited).